cobalt has been researched along with sirolimus in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 16 (64.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giorgetti-Peraldi, S; Murdaca, J; Semenza, GL; Treins, C; Van Obberghen, E | 1 |
| Abraham, RT; Chiang, GG; Giaccia, AJ; Hudson, CC; Kaper, F; Liu, M; Loomis, DC; Otterness, DM | 1 |
| Arnold, W; Giese, K; Kaufmann, J; Klippel, A; Schwarzer, R; Tondera, D | 1 |
| Rosenzweig, SA; Slomiany, MG | 1 |
| Chen, JL; Gao, RL; Hong, T; Hu, J; Huo, Y; Li, JP; Qiao, SB; Qin, XW; Shen, WF; Xu, B; Yang, YJ; Zhang, JS; Zhang, Q; Zhang, RY | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG | 1 |
| Ge, J; Ge, L; Qian, J; Zhang, F; Zhou, J | 1 |
| Domb, AJ; Farah, S; Khan, W | 1 |
| Brugaletta, S; Cequier, A; de Belder, A; de la Torre Hernandez, JM; Eberli, F; Ferrante, G; Galatius, S; Kaiser, C; Sabaté, M; Serruys, PW; Valgimigli, M | 1 |
| Li, D; Liu, F; Qi, L; Wang, M; Yan, G; Yang, T | 1 |
| Hu, ZY; Iqbal, J; Pan, DR; Pang, S; Tian, NL; Wu, W; Xu, B; Zhang, YJ; Zhu, H | 1 |
| Ahn, DJ; Han, DK; Joung, YK; Jung, JW; Lih, E | 1 |
| Ge, J; Ge, L; Qian, J; Yang, J; Zhang, F; Zhou, J | 1 |
| Chen, C; Chung, SM; Kong, X; Lee, IS; Luo, D; Yang, J; Yao, C | 1 |
| Chen, JT; Chen, RM; Cheng, BC; Chio, CC; Liu, SH; Yang, ST | 1 |
| Asano, T; de Winter, RJ; Dijkstra, J; Jonker, H; Katagiri, Y; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Stone, GW; Tanabe, K; Tenekecioglu, E; Wykrzykowska, JJ | 1 |
| Bil, J; Gil, RJ; Kern, A; Pawłowski, T | 1 |
| Anderson, R; Asano, T; Baumbach, A; Johnson, T; Kiemeneij, F; Lansky, AJ; Onuma, Y; Serruys, PW; Slagboom, T; Van Royen, N; Vlachojannis, G; Wijns, W; Xu, B; Zheng, M | 1 |
| Bedair, TM; Han, DK; Joung, YK; Min, IJ; Park, W | 1 |
| Chen, D; Chen, Z; Dai, C; Han, Z; He, F; Li, Y; Tan, R; Tian, H; Wang, G; Wang, M; Wei, L; Yang, B; Yang, H; Zhang, B | 1 |
| Bil, J; Gąsior, M; Gil, RJ; Kern, A; Legutko, J; Lesiak, M; Pawłowski, T; Witkowski, A | 1 |
| Aoki, J; Awata, M; Kashiwabara, K; Kimura, T; Kozuma, K; Matsuyama, Y; Nanasato, M; Oba, K; Shinozaki, T; Shiode, N; Tanabe, K; Yamaguchi, J | 1 |
| Asano, T; Chichareon, P; Digne, F; Gil, RJ; Kogame, N; Lefèvre, T; Legutko, J; Modolo, R; Morel, MA; Onuma, Y; Serruys, PW | 1 |
| Pavithran, S; Rajendran, M; Ramasamy, R; Sivakumar, K; Sonawane, B | 1 |
| Choi, YJ; Kang, JM; Kang, WS; Kim, SH; Park, HJ; Park, JH; Park, Y; Ryu, DS | 1 |
2 review(s) available for cobalt and sirolimus
| Article | Year |
|---|---|
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2014 |
Cobalt chromium-based biodegradable polymer sirolimus-eluting stent: rationale, evidence and clinical experience.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug Liberation; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Polymers; Prosthesis Design; Sirolimus; Thrombosis | 2015 |
5 trial(s) available for cobalt and sirolimus
| Article | Year |
|---|---|
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States | 2009 |
Two-year clinical outcomes of patients with the second-generation cobalt-chromium sirolimus-eluting stents from the real-world FOCUS registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Cohort Studies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Registries; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic le
Topics: Atherosclerosis; Chromium; Cobalt; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Europe; Humans; Neointima; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2018 |
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent.
Topics: Acute Coronary Syndrome; Chromium; Cobalt; Coronary Stenosis; Drug-Eluting Stents; Humans; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Research Design; Self Expandable Metallic Stents; Sirolimus; Treatment Outcome | 2019 |
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
Topics: Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Treatment Outcome | 2020 |
18 other study(ies) available for cobalt and sirolimus
| Article | Year |
|---|---|
Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway.
Topics: Animals; Cell Line; Cell Nucleus; Cobalt; DNA-Binding Proteins; Endothelial Growth Factors; Gene Expression Regulation; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Kinetics; Lymphokines; Mitogen-Activated Protein Kinases; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Pigment Epithelium of Eye; Plasmids; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; Transcription Factors; Transcription, Genetic; Transfection; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
Topics: Cell Hypoxia; Chromones; Cobalt; DNA-Binding Proteins; Enzyme Inhibitors; Glucose Transporter Type 1; Helix-Loop-Helix Motifs; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Monosaccharide Transport Proteins; Morpholines; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured | 2002 |
REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Chromones; Cobalt; Dimethyl Sulfoxide; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; RNA, Antisense; Signal Transduction; Sirolimus; Transcription Factors; Up-Regulation | 2005 |
Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion.
Topics: Anti-Bacterial Agents; Cell Line; Cobalt; Gene Expression Regulation; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Immunoblotting; Immunohistochemistry; Insulin-Like Growth Factor I; Ligands; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Sirolimus; Stimulation, Chemical; Transfection; Vascular Endothelial Growth Factor A | 2006 |
Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study.
Topics: Aged; Angioplasty, Balloon, Coronary; Cobalt; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Sirolimus; Stents; Ultrasonography, Interventional | 2007 |
Crystalline coating of rapamycin onto a stent: process development and characterization.
Topics: Chromium; Cobalt; Crystallization; Drug-Eluting Stents; Microscopy, Atomic Force; Powder Diffraction; Sirolimus; Surface Properties; X-Ray Diffraction | 2013 |
Regulation on Beclin-1 expression by mTOR in CoCl2-induced HT22 cell ischemia-reperfusion injury.
Topics: Analysis of Variance; Animals; Antimutagenic Agents; Apoptosis Regulatory Proteins; Beclin-1; Brain Ischemia; Cell Line; Cell Survival; Cobalt; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Mice; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sirolimus | 2015 |
Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co-Cr substrates for prevention of initial in-stent restenosis.
Topics: Anti-Inflammatory Agents; Aspirin; Cells, Cultured; Chromium Alloys; Cobalt; Coronary Restenosis; Drug Liberation; Drug Synergism; Drug-Eluting Stents; Humans; Microscopy, Electron, Scanning; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyesters; Prasugrel Hydrochloride; Propolis; Sirolimus | 2016 |
Comparison of long-term clinical outcomes after the second-generation cobalt-chromium sirolimus-eluting stents implantation in diabetic versus non-diabetic patients: a subgroup analysis from the prospective FOCUS registry.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Treatment Outcome | 2016 |
Biomimetic apatite formed on cobalt-chromium alloy: A polymer-free carrier for drug eluting stent.
Topics: Apatites; Arteries; Biomimetic Materials; Cell Adhesion; Cell Proliferation; Chromium Alloys; Cobalt; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Humans; Myocytes, Smooth Muscle; Polymers; Porosity; Sirolimus; Surface Properties; X-Ray Diffraction | 2017 |
Cobalt chloride treatment induces autophagic apoptosis in human glioma cells via a p53-dependent pathway.
Topics: Adenine; Antimutagenic Agents; Apoptosis; Autophagy; Brain Neoplasms; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Cobalt; Glioma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Microtubule-Associated Proteins; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sirolimus; Tumor Suppressor Protein p53 | 2017 |
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Topics: Absorbable Implants; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Sirolimus | 2017 |
First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® - three-month results.
Topics: Acute Coronary Syndrome; Aged; Angina, Stable; Chromium; Cobalt; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Poland; Registries; Sirolimus; Treatment Outcome | 2018 |
Sustained drug release using cobalt oxide nanowires for the preparation of polymer-free drug-eluting stents.
Topics: Alloys; Anti-Infective Agents; Chromium; Cobalt; Delayed-Action Preparations; Drug Liberation; Drug-Eluting Stents; Nanowires; Oxides; Sirolimus | 2018 |
Autophagy and Akt in the protective effect of erythropoietin helix B surface peptide against hepatic ischaemia/reperfusion injury in mice.
Topics: Adenine; Animals; Autophagosomes; Autophagy; Cell Line; Chemical and Drug Induced Liver Injury; Chromones; Cobalt; Disease Models, Animal; Erythropoietin; Humans; Liver; Liver Function Tests; Mice; Mice, Inbred C57BL; Morpholines; Peptide Fragments; Proto-Oncogene Proteins c-akt; Random Allocation; Reperfusion Injury; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2018 |
Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Female; Hospitals, University; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Product Surveillance, Postmarketing; Prognosis; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Sirolimus; Survival Analysis; Treatment Outcome | 2019 |
Serum Sirolimus Levels After Implantation of Third Generation Drug Eluting Cobalt Chromium Coronary Stent in Ductus Arteriosus in Neonates with Duct-Dependent Pulmonary Circulation.
Topics: Chromium; Cobalt; Drug-Eluting Stents; Ductus Arteriosus, Patent; Female; Heart Ventricles; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Prospective Studies; Prosthesis Implantation; Pulmonary Atresia; Pulmonary Circulation; Sirolimus; Treatment Outcome; Ventricular Septum | 2020 |
Sirolimus-eluting cobalt-chrome alloy stent suppresses stent-induced tissue hyperplasia in a porcine Eustachian tube model.
Topics: Animals; Chromium Alloys; Cobalt; Drug-Eluting Stents; Eustachian Tube; Hyperplasia; Sirolimus; Stents; Swine; Treatment Outcome | 2022 |